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ulum and the Golgi apparatus. We demonstrated that overexpression of UDP-GlcNAc transporter
(NGT) in MDCK-RCAr and CHO-Lec8 mutant cells defective in UDP-Gal transporter (UGT) restored
galactosylation of N-glycans. NGT overexpression resulted in decreased transport of UDP-GlcNAc
into the Golgi vesicles. This effect resembled the phenotype of mutant cells corrected by UGT1 over-
expression. The transport of UDP-Gal was not signiﬁcantly changed. Our data suggest that the bio-
logical function of UGT and NGT in galactosylation of macromolecules may be coupled.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glycosylation of macromolecules occurs in the lumen of the
endoplasmic reticulum (ER) and the Golgi apparatus. The sub-
strates required by glycosyltransferases are sugars activated by
the addition of a nucleoside mono- or diphosphate (UDP, GDP, or
CMP). To be available for glycosyltransferases, they must be trans-
ported into the ER or Golgi apparatus by nucleotide sugar trans-
porters (NSTs) [1,2], which are hydrophobic transmembrane
proteins. It has been proposed that NSTs act as antiporters,
exchanging the nucleotide sugar with the corresponding nucleo-
side monophosphate, which is a product of the glycosylation
reaction.
The ﬁrst characterized NSTs were speciﬁc for the translocation
of a single nucleotide sugar [1,2]. Recently, multisubstrate
transporters of nucleotide sugars have been described, including
UDP-GlcNAc transporter (NGT). NSTs transporting UDP-GlcNAc as
a single activity [3,4] or as one of several activities [5–7] have been
identiﬁed. It has been reported that mutation in the SLC35A3 gene
encoding NGT resulted in complex vertebral malformations [8].
One of the best characterized NSTs is the UDP-Gal transporter
(UGT) [9–14]. Detailed characterization of this protein was possi-chemical Societies. Published by E
s; UGT, UDP-Gal transporter;
pl (M. Olczak).ble after mutant cell lines, such as Madin-Darby canine kidney II
cells resistant to Ricinus communis agglutinin (MDCK-RCAr)
[15,16], Chinese hamster ovary-Lec8 (CHO-Lec8) [11], and murine
Had-1 [17], had been generated. Previously, two splice variants of
UDP-Gal transporter (UGT1 and UGT2) have been identiﬁed in hu-
mans [9,10], but only single orthologs have been found in CHO
[11], MDCK [12], and murine cells [14]. Recently, we identiﬁed a
UGT1-like isoform in CHO cells and a UGT2-like isoform in MDCK
cells [18]. The MDCK cells, both wild-type and mutant, have an
additional shorter UGT isoform [12].
MDCK-RCAr and CHO-Lec8 mutant cells are enriched in cell
surface macromolecules bearing terminal N-acetylglucosamine
and signiﬁcantly reduced in galactosylation and sialylation
[11,15]. Even though UGT is not active, in mutant cells some
galactosylation occurs [19], similar to murine Had-1 cells [17].
Within known NGTs, NGT assigned as SLC35A3 (NCBI ID:
NM_012243) is assumed to play a major role in glycosylation.
Since NGT and UGT are evolutionarily closely related (amino acid
sequence identity of human, canine, or hamster UGT1 and NGT is
52%, 51%, or 51%, respectively), we suspected that their role in
galactosylation of macromolecules may be coupled. Residual
galactosylation detected in MDCK-RCAr and CHO-Lec8 mutant
cells may, at least in part, support our hypothesis. Therefore in
this study we used an in vitro model to analyze the role of canine
NGT (NCBI ID: NM_001003385) overexpression in phenotypic
correction of the UGT mutation defect in MDCK-RCAr and CHO-
Lec8 cells.lsevier B.V. All rights reserved.
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Fig. 1. UDP-GlcNAc transporter (NGT) overexpression and analysis of phenotypic
correction of MDCK-RCAr and CHO-Lec8 cells with lectins. (A) Western blotting of
6His-HA-tagged NGT in mutant cells stably transfected with expression plasmid.
(B) Phenotypic correction determined using GSL II (Griffonia simplicifolia lectin II
speciﬁc for terminal N-acetylglucosamine) and MAL I (Maackia amurensis lectin I
speciﬁc for terminal galactose and alpha 2,3-sialic acid-galactose). (C) Expression
levels of beta-actin. Cell lysates (A) or extracted proteins (B, C) were separated by
SDS–PAGE (20 lg) and transferred onto nitrocellulose membranes. Overexpressed
NGT was visualized with HRP-conjugated anti-HA antibody. Biotinylated lectins
attached to glycoproteins were detected using AP-conjugated avidin D. Represen-
tative data out of three independent sets with a similar pattern are shown. C, Cells
transfected with empty plasmid; 1–3, clones overexpressing NGT.
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2.1. Construction of mammalian expression plasmids, cell maintenance
and transfection
Constructs containing NGT or UGT1 encoding native sequences
or N-terminal tagged versions were prepared and stable transfec-
tants selected in complete media [18]. Alternatively, MDCK and
MDCK-RCAr cells were grown in EX-CELL MDCK serum-free med-
ium (Sigma–Aldrich) supplemented with 6 mM L-glutamine,
100 IU penicillin/ml and 100 lg/ml streptomycin, and CHO and
CHO-Lec8 cells were grown in SFM4CHO-A serum-free medium
(Thermo Scientiﬁc) supplemented with 4 mM L-glutamine, 100 IU
penicillin/ml and 100 lg/ml streptomycin.
2.2. Analysis of glycoproteins with lectins
Cells adapted to serum-free culture conditions were collected
and lysed using Complete Lysis-M reagent (Roche) supplemented
with protease inhibitor cocktail and 1 mM EDTA. Aliquots contain-
ing 20 lg of total proteins were separated by SDS–PAGE and trans-
ferred onto nitrocellulose membranes (Whatman) [18]. Equal
protein loading was determined by detecting a product of a house-
keeping gene using chicken antibody directed against beta-actin
(Abcam) and goat anti-chicken IgY HRP-conjugated antibody (Ab-
cam). For the detection of glycans bound to glycoproteins, lectin
speciﬁc for terminal N-acetylglucosamine (Griffonia simplicifolia
lectin II, GSL II) and lectin speciﬁc for terminal galactose and alpha
2,3-sialic acid-galactose attached (Maackia amurensis lectin I, MAA I)
were used. After blocking with Carbo-Free Blocking Solution, mem-
branes were incubated with biotinylated lectins (Vector Laborato-
ries) in 50 mM Tris–HCl, pH 7.5, containing 150 mM NaCl (TBS),
0.2% Tween-20, 1 mMMg2+, 1 mM Ca2+ and 1 mM Mn2+. Lectin
binding was detected using AP-conjugated avidin D (Vector
Laboratories) and visualized with NBT/BCIP solution (Roche).
2.3. Isolation and separation of ﬂuorescently labeled N-glycans
Cell lysates were diluted to 2 mg/ml using the lysis buffer,
and 500-ll aliquots were precipitated overnight at 20 C with
an equal volume of cold acetone. After centrifugation at
10000g for 10 min, precipitates were air-dried and resus-
pended in glycoprotein denaturation buffer (N-glycosidase F
deglycosylation enzyme pack, New England Biolabs). Deglycosy-
lation was performed using 1 ll of the enzyme (500 U) for
18 h at 37 C in deglycosylation buffer. Released N-glycans were
isolated on 50 mg Hypercarb graphite SPE columns (Thermo
Electron) using the protocol described for GlycoClean H SPE col-
umns I (Glyko) and dried (Maxi Dry Lyo, Heto). Glycans were
ﬂuorescently labeled with 2-aminobenzamide (2-AB) [20] and
puriﬁed on a 1-mm 3MM blotting ﬁlter paper (Whatman)
placed on the bottom of an empty glass column (1 cm diameter)
with the procedure identical to the protocol described for Glyc-
oClean S cartridges (Glyko). Small fractions of all samples (5–
15%) were separated on a GlycoSep N normal-phase column
(Glyko) using the high salt solvent system (HSSS) [21] and the
Series 200 HPLC system equipped with a 200a ﬂuorescence
detector (Perkin Elmer).
2.4. MALDI-TOF mass spectrometric (MS) analysis of N-glycans
Prior to MALDI-TOF MS analysis, both the 2-AB labeled glycan
pool puriﬁed on Hypercarb graphite SPE columns and samples col-
lected after separation on a GlycoSep N column were additionally
puriﬁed using Hypersep Hypercarb 10–200 ll tips (Thermo Elec-
tron). Samples were dissolved in 10 ll of 2% acetonitrile containing0.05% TFA. Bound glycans were washed with the same solution and
eluted with 10 ll of 50% acetonitrile containing 0.05% TFA. Eluted
glycans were dried (Maxi Dry Lyo) and subsequently dissolved in
1 ll of 20% acetonitrile. N-Glycans derived from MDCK cells were
additionally treated with neuraminidase from Clostridium perfrin-
gens (New England Biolabs). Reactions were performed overnight
at 37 C in 50 ll of G1 buffer (New England Biolabs) containing
50 U of the enzyme. Samples were ﬁltered using 5 kDa Ultrafree
MC spin columns (Millipore).
Membraneswerewashed twicewith 100 ll ofMilli-Qwater. The
ﬁltrate andwashingswere combined, dried, resuspended in 10 ll of
Milli-Q water and desalted using Hypersep Hypercarb 10–200 ll
tips. Dried samples were resuspended in 1 ll of 20% acetonitrile.
MALDI-TOF MS was performed in positive ion mode with Na+
excess. Puriﬁed samples (1 ll) were spotted onto the metal plate
of an MS 4800 Plus MALDI TOF/TOF Analyzer (AB Sciex). After
drying, 1 ll of Super-DHB matrix (Sigma–Aldrich) solution
(20 g/ml), freshly dissolved in 20% (v/v) acetonitrile containing
20 mM sodium acetate, was added. After drying, the spectra
were recorded within the 1000–3500 Da range. For each spot,
spectra were obtained from 1000 laser shots (40 subspectra,
25 shots/subspectrum) with 200 s1 laser shot frequency and la-
ser power of 7400 AU. Glycans were identiﬁed by comparing
experimental data expressed in GU, obtained as a result of HPLC
separation on a GlycoSep N column, with data deposited in
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Fig. 2. MALDI-TOF MS analysis of N-glycans performed in positive ion mode. Glycans released from glycoproteins isolated from CHO-Lec8 and CHO-Lec8 overexpressing UDP-
GlcNAc transporter (NGT) were identiﬁed by comparing experimental data expressed in GU, obtained as a result of HPLC separation on a GlycoSep N column, with data from
GlycoBase 3.0 (The National Institute for Bioprocessing Research and Training, Dublin, Ireland), followed by comparing these data with molecular weights of respective
structures, experimentally determined using MALDI-TOF MS. N-Glycan composition was subsequently calculated using the GlycoMod tool [22]. Representative data out of 2–
8 independent measurements with a similar tendency are shown. Black arrows, respective peaks; red arrows, peaks showing increased content of respective galactosylated
glycans after NGT overexpression; blue squares, N-acetylglucosamine (GlcNAc); green circles, mannose (Man); yellow circles, galactose (Gal); red triangles, fucose (Fuc).
3092 D. Maszczak-Seneczko et al. / FEBS Letters 585 (2011) 3090–3094GlycoBase 3.0 (The National Institute for Bioprocessing Research
and Training, Dublin, Ireland), followed by comparing these data
with molecular weights of respective structures, experimentally
determined using MALDI-TOF MS. N-Glycan composition was
subsequently calculated using the GlycoMod tool [22].
2.5. Subcellular fractionation, Western blotting and nucleotide sugar
transport assay
The Golgi fractionwas isolated [23] and proteins from respective
fractions were separated by SDS–PAGE, transferred onto nitrocellu-
losemembranes, anddetected [18].UDP-Gal andUDP-GlcNAc trans-
port into theGolgi vesicleswas determinedwithmodiﬁcations [24].
Reactionswere carriedout for10 minat30 C in0.2-ml samples con-
taining either 20 lM cold UDP-Gal (Sigma–Aldrich) and 5 lCi tri-
tium-labeled UDP-Gal (American Radiolabeled Chemicals, 20 Ci/
nmol) or 20 lM cold UDP-GlcNAc (Sigma–Aldrich) and 5 lCi tri-
tium-labeled UDP-GlcNAc (American Radiolabeled Chemicals,
800 Ci/nmol).
3. Results and discussion
3.1. Reactivity of glycoproteins with lectins
In this study we characterized both native and N-tagged ver-
sions of NGT. Results of phenotypic correction analysis were simi-lar for each clone examined (data not shown); therefore data for
6His-HA tagged NGT, which can be easily monitored with anti-
HA antibody (Fig. 1A), are shown. Lectin analysis demonstrated
that glycoproteins synthesized by mutant cells partially lost their
reactivity to the GSL II lectin after overexpression of NGT
(Fig. 1B). This suggests that, at least in part, more galactose was at-
tached to terminal GlcNAc. Analysis with MAL I lectin showed
higher reactivity with glycoproteins produced by the MDCK-RCAr
mutant cells compared to the CHO-Lec8 mutant cells, both over-
expressing NGT (Fig. 1B). This suggests that MDCK cells produce
higher amounts of terminal galactose with sialic acid attached.3.2. Identiﬁcation of glycan structures
To identify structural changes, N-glycans isolated from glyco-
proteins were examined using MALDI-TOF MS (Fig. 2 and Supple-
mentary Table S1). We analyzed neutral N-glycans of CHO cells
directly in positive ion mode. Here we showed that overexpression
of NGT in CHO-Lec8 mutant cells resulted in increased content of
structures containing galactose (Fig. 2, bottom panel), compared
with the CHO-Lec8 mutant cells (Fig. 2, top panel). In addition,
NGT overexpression resulted in decreased content of glycans with
terminal GlcNAc. The effect observed in MDCK cells was less pro-
nounced than in CHO cells. Our preliminary data showed that, in
contrast to CHO cells, MDCK cells produce neutral N-glycans
1000 1460 1920 2380 2840 3300
3653.7
0
10
20
30
40
50
60
70
80
90
100
%
 In
te
ns
ity
11
99
.5
89
0
15
39
.7
10
6
13
77
.6
46
7
10
53
.5
21
1
20
25
.8
99
4
17
01
.7
78
0
18
63
.8
32
2
19
29
.8
92
9
21
32
.9
76
6
16
05
.7
84
3
22
95
.0
36
6
17
83
.8
27
5
19
86
.9
21
9
21
87
.9
73
1
26
60
.2
04
8
24
98
.1
20
8
16
62
.8
31
2
28
22
.2
49
3
30
25
.3
14
5
31
87
.3
22
3
29
68
.3
01
0
1000 1460 1920 2380 2840 3300
Mass (m/z)
1820.8
0
10
20
30
40
50
60
70
80
90
100
%
 In
te
ns
ity
11
99
.5
95
2
15
39
.7
27
3
18
08
.8
85
6
18
63
.8
58
2
10
53
.5
30
8
13
77
.6
70
0
17
01
.8
01
1
20
25
.9
33
1
22
15
.0
79
6
16
05
.7
83
3
17
83
.8
73
7
14
02
.6
96
2
20
69
.0
03
7
14
59
.7
26
3
21
74
.0
20
8
19
70
.9
81
3
12
56
.6
43
6
23
77
.1
59
7
Fig. 3. MALDI-TOF MS analysis of N-glycans performed in positive ion mode. Glycans released from glycoproteins isolated from MDCK-RCAr and MDCK-RCAr overexpressing
UDP-GlcNAc transporter (NGT) were desialylated and identiﬁed by comparing experimental data expressed in GU, obtained as a result of HPLC separation on a GlycoSep N
column, with data from GlycoBase 3.0 (The National Institute for Bioprocessing Research and Training, Dublin, Ireland), followed by comparing these data with molecular
weights of respective structures, experimentally determined using MALDI-TOF MS. N-Glycan composition was subsequently calculated using the GlycoMod tool [22].
Representative data out of 2–8 independent measurements with a similar tendency are shown. Black arrows, respective peaks; red arrows, peaks showing increased content
of respective glycans after NGT overexpression; blue squares, N-acetylglucosamine (GlcNAc); green circles, mannose (Man); yellow circles, galactose (Gal); red triangles,
fucose (Fuc).
D. Maszczak-Seneczko et al. / FEBS Letters 585 (2011) 3090–3094 3093comprising only traces of attached galactose (Fig. 1B and data not
shown). Therefore, prior MALDI-TOF MS isolated glycans were
desialylated. NGT overexpression resulted in biosynthesis of
branched and highly galactosylated structures (Fig. 3, bottom pa-
nel), not present in MDCK-RCAr mutant cells (Fig. 3, top panel).
The correction effect is even more visible in the disappearance of
glycans speciﬁc for MDCK-RCAr cells containing terminal GlcNAc
(Supplementary Table S1, structures 8, 9, 10, 23, 26). We also ob-
served slightly increased content of high-mannose structures after
NGT overexpression, especially in CHO-Lec8 cells. One might sug-
gest that it may be a cell line-speciﬁc feature.
3.3. Analysis of nucleotide sugar transport
Previously we demonstrated that overexpressed transporters
were properly localized to the Golgi apparatus. Isolated Golgi
vesicles were examined for their ability to transport UDP-Gal or
UDP-GlcNAc. As expected, signiﬁcantly lower UDP-Gal transport
in mutant cells was fully corrected by overexpression of UGT1
(unpublished data). Based on the phenotype examined with GSL
II lectin we expected increased UDP-Gal transport into Golgi
vesicles after overexpression of NGT. However, mutant cells over-
expressing this transporter showed UDP-Gal transport activity
comparable to mutant cells (Fig. 4). Similar to published data[9,15,25], mutant cells defective in UGT exhibited higher activity
of UDP-GlcNAc transport. Correction of the mutation by UGT1
overexpression decreased UDP-GlcNAc transport to a level compa-
rable to that found in the wild type cells. The nature of this effect
has never been examined, but it may indicate that UGT and
NGT may be coupled in galactosylation of macromolecules.
Surprisingly, overexpression of NGT resulted in decreased
transport activity of UDP-GlcNAc (Fig. 4). It is worth noting that
transport activity of CHO-Lec8 cells overexpressing NGT was sig-
niﬁcantly lower compared to both mutant and wild type cells. This
unexpected tendency is similar to the correction of the mutant
cells by UGT1 overexpression.
4. Conclusions
Here we demonstrate that overexpression of NGT may partially
restore galactosylation of N-glycans in MDCK-RCAr and CHO-Lec8
mutant cells defective in UGT. Our data suggest that the biological
function of UGT and NGT in galactosylation of macromolecules
may be coupled. High homology and similar behavior of overex-
pressed NGT or UGT in the mutant cells may suggest that both
transporters may partially replace the function played by its part-
ner, comprising a membrane protein complex composed of these
transporters and speciﬁc glycosyltransferases.
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Fig. 4. Nucleotide sugar transport assay. Transport of UDP-Gal (A) and UDP-GlcNAc
(B) into Golgi vesicles derived from MDCK or CHO wild type, mutant and mutant
cells overexpressing UDP-GlcNAc transporter (NGT) was determined. Data are
shown as mean ± standard deviation from 3 to 5 independent experiments
performed in duplicate.
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